Posts
Following the US Food and Drug
Administration’s (FDA’s) official announcement on January 18 of a doxycycline
shortage, quantities of the drug remain in short supply.
The decreased availability is due in
part to both manufacturing delays and use of the drug as a primary treatment
for many sexually transmitted diseases such as chlamydia, nongonococcal
urethritis, epididymitis, and pelvic inflammatory disease.
CDC has provided a series of
alternative treatment options for physicians to consider for their patients at http://www.cdc.gov/std/treatment/doxycyclineShortage.htm.
FDA has listed additional
information on manufacturer status regarding the antibiotic, contact
information, and other commentary at http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#doxycycline.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!
